Cargando…

Fibroscan® probe selection for lean adults

BACKGROUND AND AIM: Fibroscan® is used to assess fibrosis and steatosis of the liver noninvasively. The company suggests to use the S+‐probe in people <18 years with a thoracic circumference (TC) between 45 and 75 cm and the M+‐probe in children with a TC >75 cm and adults with a skin–liver ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stadlbauer, Vanessa, Negrean, Iohanes, Posch, Andreas, Streit, Andrea, Feldbacher, Nicole, Stauber, Rudolf E, Horvath, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264238/ https://www.ncbi.nlm.nih.gov/pubmed/34263068 http://dx.doi.org/10.1002/jgh3.12579

Ejemplares similares

The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study
por: Horvath, Angela, et al.
Publicado: (2020)

Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes
por: Spindelboeck, Walter, et al.
Publicado: (2016)

Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study
por: Horvath, Angela, et al.
Publicado: (2019)

Serum bile acids in liver cirrhosis promote neutrophil dysfunction
por: Balazs, Irina, et al.
Publicado: (2022)

Points to Be Considered When Applying FibroScan S Probe in Children With Biliary Atresia
por: Kim, Seung, et al.
Publicado: (2014)

Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
por: Berger, Arthur, et al.
Publicado: (2019)

Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
por: Stadlbauer, Vanessa, et al.
Publicado: (2020)

Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy
por: Malekzadeh, Reza, et al.
Publicado: (2011)

Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut–Liver Axis: A Case Control Study
por: Blesl, Andreas, et al.
Publicado: (2020)

Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients
por: Durango, Esteban, et al.
Publicado: (2013)

A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers
por: Stadlbauer, Vanessa, et al.
Publicado: (2019)

Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial
por: Pilz, Stefan, et al.
Publicado: (2016)

Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years
por: Zeng, Jing, et al.
Publicado: (2019)

Update of liver fibrosis and steatosis with transient elastography (Fibroscan)
por: Wong, Grace Lai-Hung
Publicado: (2013)

Diagnostic Accuracy of FibroScan and Factors Affecting Measurements
por: Oeda, Satoshi, et al.
Publicado: (2020)

The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan–aspartate aminotransferase to predict severity of liver disease in children
por: Chaidez, Alexander, et al.
Publicado: (2022)

Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure
por: Stadlbauer, Vanessa, et al.
Publicado: (2006)

Quantitative Evaluation of Liver Fibrosis on T1 Relaxometry in Comparison with Fibroscan
Publicado: (2020)

Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice
por: Armstrong, M J, et al.
Publicado: (2013)

Exploring the Potential Performance of Fibroscan for Predicting and Evaluating Metabolic Syndrome using a Feature Selected Strategy of Machine Learning
por: Chiu, Kuan-Lin, et al.
Publicado: (2023)

Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis
por: Horvath, Angela, et al.
Publicado: (2020)

The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease
por: Wilder, Julius, et al.
Publicado: (2014)

Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B
por: HUANG, RENGANG, et al.
Publicado: (2016)

A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis
por: Jun, Baek Gyu, et al.
Publicado: (2017)

Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
por: Shrestha, Rupesh, et al.
Publicado: (2021)

The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Correlation Between Serum Ferritin and Degree of Hepatic Fibrosis on Fibroscan in Thalassemic Patients
por: Ali, Muhammad Shujat, et al.
Publicado: (2023)

Correlates of hepatic stiffness by FibroScan(©) in a multicentric Italian cohort of HIV-infected patients
por: Tarquini, P, et al.
Publicado: (2010)

Validation of Malnutrition Screening Tools in Liver Cirrhosis
por: Traub, Julia, et al.
Publicado: (2020)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010)

Can We Accurately Assess Liver Fibrosis with Fibroscan® Using Fewer Valid Measurements?
por: Pournik, Omid, et al.
Publicado: (2013)

Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
por: Chan, Yin, et al.
Publicado: (2017)

Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
por: Chakraborty, Semanti, et al.
Publicado: (2020)

Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)

Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle East
por: Sawaf, Bisher, et al.
Publicado: (2020)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Correlation between Transient Elastography (Fibroscan(®)) and Ultrasonographic and Computed Tomographic Grading in Pediatric Nonalcoholic Steatohepatitis
por: Lee, Ji Eun, et al.
Publicado: (2022)

Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia
por: Kim, Kwang Woo, et al.
Publicado: (2022)

Dietary glycine decreases both tumor volume and vascularization in a combined colorectal liver metastasis and chemotherapy model
por: Maneikyte, Juste, et al.
Publicado: (2019)

NMR spectroscopy enables simultaneous quantification of carbohydrates for diagnosis of intestinal and gastric permeability
por: Stryeck, Sarah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j2k06vu8viinlqi4dqckp3d4ns